ENZ Enzo Biochem
- 1.120
- +0.030+2.75%
- 1.100
- -0.020-1.79%
Enzo Biochem News
Enzo Biochem | 8-K: Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
Enzo Biochem | 10-Q: Quarterly report
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Officer Cannon Kara
Enzo Biochem | 8-K: Current report
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Officer Eckert Patricia
Enzo Biochem | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-1 Main Capital Management, LLC(4.95%),Yaron Naymark(4.95%), etc.
Enzo Biochem | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Renaissance Technologies LLC 26-0385758(4.91 %),RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734(4.91 %)
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Director PULLY STEVEN J
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Director TAGLIAFERRI MARY
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Director Radoff Bradley Louis
Enzo Biochem | 8-K: Current report
Enzo Biochem | DEFR14A: Definitive proxy statement in connection with contested solicitations
Enzo Biochem | ARS: Annual Report to Security Holders
Enzo Biochem: Q1 2024 Earnings Report
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Director PULLY STEVEN J
Enzo Biochem | 10-K/A: Annual report (Amendment)
Enzo Biochem: FY2023 Annual Report
Enzo Biochem | NT 10-K: Others
Enzo Biochem | 3: Initial statement of beneficial ownership of securities-Director PULLY STEVEN J
Enzo Biochem | 8-K: Current report
Analysis
Price Target
No Data
